Meta‐analysis of microarray data to determine gene indicators involved in cisplatin resistance in non‐small cell lung cancer
Cancer Reports · 2024
DOI: 10.1002/cnr2.1970 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Cancer Reports, 2024. Verfasst von Somayeh Hashemi Sheikhshabani und 7 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran, Student Research Committee, Tabriz University of Medical Sciences.
Abstract (Originalsprache)
Background
Lung cancer is a major cause of cancer‐related mortality worldwide, with a 5‐year survival rate of approximately 22%. Cisplatin is one of the standard first‐line chemotherapeutic agents for non‐small cell lung cancer (NSCLC), but its efficacy is often limited by the development of resistance. Despite extensive research on the molecular mechanisms of chemoresistance, the underlying causes remain elusive and complex.
Aims
We analyzed three microarray datasets to find the gene signature and key pathways related to cisplatin resistance in NSCLC. Methods and Results We compared the gene expression of sensitive and resistant NSCLC cell lines treated with cisplatin. We found 274 DEGs, including 111 upregulated and 163 downregulated genes, in the resistant group. Gene set enrichment analysis showed the potential roles of several DEGs, such as TUBB2B , MAPK7 , TUBAL3 , MAP2K5 , SMUG1 , NTHL1 , PARP3 , NTRK1 , G6PD , PDK1 , HEY1 , YTHDF2 , CD274 , and MAGEA1 , in cisplatin resistance. Functional analysis revealed the involvement of pathways, such as gap junction, base excision repair, central carbon metabolism, and Notch signaling in the resistant cell lines.
Conclusion
We identified several molecular factors that contribute to cisplatin resistance in NSCLC cell lines, involving genes and pathways that regulate gap junction communication, DNA damage repair, ROS balance, EMT induction, and stemness maintenance. These genes and pathways could be targets for future studies to overcome cisplatin resistance in NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Student Research Committee, Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Cell and Molecular Biology and Microbiology, Faculty of Science and Technology, University of Isfahan, Isfahan, Iran.
- Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Biotechnology and Plant Breeding, Islamic Azad University Science and Research Branch, Tehran, Iran.
- Bayesian Imaging and Spatial Statistics Group, Institute of Statistics, Ludwig-Maximilian-Universität München, Munich, Germany.
- Department of Statistics, Lorestan University, Khorramabad, Iran.
ORCID-Profile: Soudeh Ghafouri-Fard, Mir Davood Omrani
Förderung
- Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- Student Research Committee, Tabriz University of Medical Sciences
Zitieren
APA
Sheikhshabani, S. H., Modarres, P., Ghafouri-Fard, S., Amini-Farsani, Z., Khodaee, L., Shaygan, N., Amini-Farsani, Z., & Omrani, M. D. (2024). Meta‐analysis of microarray data to determine gene indicators involved in cisplatin resistance in non‐small cell lung cancer. Cancer Reports. https://doi.org/10.1002/cnr2.1970
Vancouver
Sheikhshabani SH, Modarres P, Ghafouri-Fard S, Amini-Farsani Z, Khodaee L, Shaygan N, et al. Meta‐analysis of microarray data to determine gene indicators involved in cisplatin resistance in non‐small cell lung cancer. Cancer Reports. 2024. doi:10.1002/cnr2.1970
BibTeX
@article{Sheikhshabani2024,
author = {Sheikhshabani, Somayeh Hashemi and Modarres, Paratoo and Ghafouri-Fard, Soudeh and Amini-Farsani, Zeinab and Khodaee, Lavin and Shaygan, Nasibeh and Amini-Farsani, Zahra and Omrani, Mir Davood},
title = {Meta‐analysis of microarray data to determine gene indicators involved in cisplatin resistance in non‐small cell lung cancer},
journal = {Cancer Reports},
year = {2024},
doi = {10.1002/cnr2.1970}
}
EUVIMED